#CANCERSM Chat topic 11-Jul-2019: Basics of Biomarker Testing

Until just a few years ago, chemotherapy was often the only option for some cancer patients.  In just a few short years, molecular therapies and immunotherapies have become commonplace as treatments for cancer patients.  But determining whether a particular cancer patient is a candidate for these new, often very expensive, molecular and immunotherapies requires molecular biomarker testing.  For many cancer patients and their families, the role of molecular biomarker testing in their diagnosis is a unfamiliar and confusing.  How is testing performed?  How is the test result analyzed? What is involved in… Read More

#LCSM Chat 2019/01/06–Immunotherapy: What Patients Need To Know

It’s a new year, and #LCSM Chat is transitioning to monthly chats.  Our first chat is a collaborative chat across all cancer hashtag communities titled “Immunotherapy: What Patients Need to Know.” The discussion will cover all types of immunotherapy currently approved for treatment of any cancer. Chat moderator Janet Freeman-Daily (@JFreemanDaily) will be joined by special guest Lisa Rezende (@LisaRezende1), a biology educator (Assistant Professor of Practice) on the Molecular and Cellular Biology faculty at the University of Arizona.  Lisa is also a long-term volunteer cancer advocate with FORCE (Facing Our Risk of… Read More

#LCSM Chat 11/29: What’s a cancer model, and why should I care?

Once your take cancer cells out of a living body, the cancer cells die, right?  So how researchers study cancer? One way researchers study cancer is by using “cancer models.”  Cancer models are clumps of living cancer cells that exist either in a lab dish (see image above), or in animal models such as mice. Sometimes these models also include other living cells from the host environment.  It’s not exactly the same as studying a living cancer in its human host, but it does allow researchers time to study the biology of a cancer… Read More